Literature DB >> 17204567

Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis.

Robin Christensen1, Else Marie Bartels, Arne Astrup, Henning Bliddal.   

Abstract

This review aims to assess by meta-analysis of randomised controlled trials (RCTs) changes in pain and function when overweight patients with knee osteoarthritis (OA) achieve a weight loss. Systematic searches were performed and reference lists from the retrieved trials were searched. RCTs were enclosed in the systematic review if they explicitly stated diagnosis of knee OA and reported a weight change as the only difference in intervention from the control group. Outcome Measures for Arthritis Clinical Trials III outcome variables were considered for analysis. Effect size (ES) was calculated using RevMan, and meta-regression analyses were performed using weighted estimates from the random effects analyses. Among 35 potential trials identified, four RCTs including five intervention/control groups met our inclusion criteria and provided data from 454 patients. Pooled ES for pain and physical disability were 0.20 (95% CI 0 to 0.39) and 0.23 (0.04 to 0.42) at a weight reduction of 6.1 kg (4.7 to 7.6 kg). Meta-regression analysis showed that disability could be significantly improved when weight was reduced over 5.1%, or at the rate of >0.24% reduction per week. Clinical efficacy on pain reduction was present, although not predictable after weight loss. Meta-regression analysis indicated that physical disability of patients with knee OA and overweight diminished after a moderate weight reduction regime. The analysis supported that a weight loss of >5% should be achieved within a 20-week period--that is, 0.25% per week.

Entities:  

Mesh:

Year:  2007        PMID: 17204567      PMCID: PMC1856062          DOI: 10.1136/ard.2006.065904

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  68 in total

Review 1.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

Authors:  D Moher; D J Cook; S Eastwood; I Olkin; D Rennie; D F Stroup
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

Review 2.  Current and potential drugs for treatment of obesity.

Authors:  G A Bray; F L Greenway
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

3.  The bone and joint decade 2000-2010.

Authors:  A D Woolf
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

Review 4.  Dietary approaches to reducing body weight.

Authors:  A Astrup
Journal:  Baillieres Best Pract Res Clin Endocrinol Metab       Date:  1999-04

5.  [A comparison of the efficacy of conservative therapies for obese patients with osteoarthritis of the knee].

Authors:  Yoshitaka Toda
Journal:  Ryumachi       Date:  2002-10

Review 6.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

7.  Radiographic osteoarthritis and obesity.

Authors:  Abdurhman S Al-Arfaj
Journal:  Saudi Med J       Date:  2002-08       Impact factor: 1.484

8.  The Arthritis, Diet and Activity Promotion Trial (ADAPT): design, rationale, and baseline results.

Authors:  Gary D Miller; W Jack Rejeski; Jeff D Williamson; Timothy Morgan; Mary Ann Sevick; Richard F Loeser; Walt H Ettinger; Stephen P Messier
Journal:  Control Clin Trials       Date:  2003-08

9.  Years of life lost due to obesity.

Authors:  Kevin R Fontaine; David T Redden; Chenxi Wang; Andrew O Westfall; David B Allison
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  Prevalence and trends in obesity among US adults, 1999-2000.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

View more
  161 in total

Review 1.  Biological aspects of early osteoarthritis.

Authors:  Henning Madry; Frank P Luyten; Andrea Facchini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-19       Impact factor: 4.342

Review 2.  Effects of exercise and physical activity on knee osteoarthritis.

Authors:  Stephan Esser; Allison Bailey
Journal:  Curr Pain Headache Rep       Date:  2011-12

Review 3.  Managing osteoarthritis.

Authors:  Shirley P Yu; David J Hunter
Journal:  Aust Prescr       Date:  2015-08-03

Review 4.  Short- and long-term therapeutic effects of thermal mineral waters in knee osteoarthritis: a systematic review of randomized controlled trials.

Authors:  Taoufik Harzy; Najoua Ghani; Nessrine Akasbi; Wafaa Bono; Chakib Nejjari
Journal:  Clin Rheumatol       Date:  2009-02-19       Impact factor: 2.980

Review 5.  [Non-surgical treatment of osteoarthritis of large joints - new aspects].

Authors:  Ernst Wagner
Journal:  Wien Med Wochenschr       Date:  2009

6.  The effects of laparoscopic sleeve gastrectomy on head, neck, shoulder, low back and knee pain of female patients.

Authors:  Tuğrul Çakır; Mehmet Tahir Oruç; Arif Aslaner; Fatih Duygun; Erdem Can Yardımcı; Burhan Mayir; Nurullah Bülbüller
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 7.  Knee osteoarthritis diagnosis, treatment and associated factors of progression: part II.

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2011

8.  Analyzing the Psychometric Properties of the Short Form-36 Quality of Life Questionnaire in Patients with Obesity.

Authors:  Rashed Al Amer; Khalid Al Khalifa; Safeyah Ali Alajlan; Ahmed Al Ansari
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 9.  The benefit of nonpharmacologic therapy to treat symptomatic osteoarthritis.

Authors:  Yvonne C Lee; Robert H Shmerling
Journal:  Curr Rheumatol Rep       Date:  2008-01       Impact factor: 4.592

Review 10.  Tackling obesity in knee osteoarthritis.

Authors:  Anita E Wluka; Cate B Lombard; Flavia M Cicuttini
Journal:  Nat Rev Rheumatol       Date:  2012-12-18       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.